Comparative analysis of software for physiologically based pharmacokinetic modeling: Simulation, optimization, and sensitivity analysis

被引:17
|
作者
Easterling, MR
Evans, MV
Kenyon, EM
机构
[1] US EPA, NHEERL, ETD, Res Triangle Pk, NC 27711 USA
[2] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC USA
来源
TOXICOLOGY METHODS | 2000年 / 10卷 / 03期
关键词
PBPK modeling; sensitivity analysis; simulation software;
D O I
10.1080/10517230050121615
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Historically, a number of different software packages running on a variety of hardware platforms have been used for model simulation. SimuSolv found wide use because of its broad capabilities, including optimization, statistical analysis, and formalized sensitivity analysis as well as the capacity to incorporate user-supplied subroutines. However in the early 1990s, SimuSolv development ceased and a final version was released in 1999. Thus SimuSolv will not be developed for newer platforms and operating systems. In this article, we compare and contrast the use of SimuSolv and Matlab (The MathWorks, Natick, MA) for physiologically based pharmacokinetic (PBPK) model implementation with respect to parameter estimation (optimization) and sensitivity analysis using a PBPK model for trichloroethylene (TCE). In both packages, it is possible to code PBPK models, run simulations, estimate parameters, and do sensitivity analysis. The hey difference is the additional programming required in Matlab. Since Matlab does not have built-in estimation and sensitivity routines, it was necessary to write them for the Matlab TCE model. Additionally, Matlab handles flow control differently from SimuSolv, so the model code is written in a different order than for SimuSolv. In spite of the additional coding requirements, Matlab is a well-supported and mathematically oriented simulation software package that is clearly suitable for application to PBPK modeling. All of the modeling tasks done in SimuSolv could also be done readily in Matlab. Most of the comparisons made to SimuSolv also carry over to ACSL-Tox, however ACSL-Tox calculates some sensitivity coefficients very differently from the way they are defined in SimuSolv. Future development of art interpreter for Matlab would make modeling, sensitivity analysis, and parameter estimation less programming-intensive.
引用
收藏
页码:203 / 229
页数:27
相关论文
共 50 条
  • [1] SENSITIVITY ANALYSIS FOR PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    HETRICK, DM
    JARABEK, AM
    TRAVIS, CC
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1991, 19 (01): : 1 - 20
  • [2] Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: A sensitivity analysis
    Nestorov, IA
    Aarons, LJ
    Rowland, M
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1997, 25 (04): : 413 - 447
  • [3] Physiologically Based Pharmacokinetic Modeling of a Homologous Series of Barbiturates in the Rat: A Sensitivity Analysis
    Ivan A. Nestorov
    Leon J. Aarons
    Malcolm Rowland
    Journal of Pharmacokinetics and Biopharmaceutics, 1997, 25 : 413 - 447
  • [4] Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools
    Kutumova, Elena O.
    Akberdin, Ilya R.
    Kiselev, Ilya N.
    Sharipov, Ruslan N.
    Egorova, Vera S.
    Syrocheva, Anastasiia O.
    Parodi, Alessandro
    Zamyatnin, Andrey A.
    Kolpakov, Fedor A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [5] Physiologically based pharmacokinetic (PBPK) modeling and simulation: Applications in lead optimization
    Peters, Sheila Annie
    Ungell, Anna-Lena
    Dolgos, Hugues
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 509 - 518
  • [6] Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models
    Nestorov, IA
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1999, 27 (06): : 577 - 596
  • [7] Sensitivity Analysis of Pharmacokinetic and Pharmacodynamic Systems: I. A Structural Approach to Sensitivity Analysis of Physiologically Based Pharmacokinetic Models
    Ivan A. Nestorov
    Journal of Pharmacokinetics and Biopharmaceutics, 1999, 27 : 577 - 596
  • [8] Physiologically Based Pharmacokinetic Modeling and Simulation of Sunitinib in Pediatrics
    Yu, Yanke
    DuBois, Steven G.
    Wetmore, Cynthia
    Khosravan, Reza
    AAPS JOURNAL, 2020, 22 (02):
  • [9] Physiologically Based Pharmacokinetic Modeling and Simulation of Sunitinib in Pediatrics
    Yanke Yu
    Steven G. DuBois
    Cynthia Wetmore
    Reza Khosravan
    The AAPS Journal, 22
  • [10] Applying a Global Sensitivity Analysis Workflow to Improve the Computational Efficiencies in Physiologically-Based Pharmacokinetic Modeling
    Hsieh, Nan-Hung
    Reisfeld, Brad
    Bois, Frederic Y.
    Chiu, Weihsueh A.
    FRONTIERS IN PHARMACOLOGY, 2018, 9